Open sidebar
Focus
merck
COVID News
|
Caden Pearson
Study Links Merck’s COVID-19 Antiviral Pill to Mutated Strains
The findings published in the journal Nature suggests that molnupiravir may enable mutated viruses to spread.
Sep 25, 2023
|
Caden Pearson
Sep 25
|
Companies
|
Ryan Morgan
Top 5 US Pharma Companies Netted $82 Billion in 2022: Report
Jul 25, 2023
|
Ryan Morgan
Jul 25
|
US News
|
Caden Pearson
Johnson & Johnson Sues to Block Medicare Drug Price Negotiations
Jul 18, 2023
|
Caden Pearson
Jul 18
|
Health & Safety
|
Naveen Athrappully
Merck Facing Lawsuits for Allegedly Hiding Severe Psychiatric Side Effects of Asthma Drug
Jun 26, 2023
|
Naveen Athrappully
Jun 26
|
Executive Branch
|
Emel Akan
Merck Sues Biden Administration Over ‘Sham’ Drug Price Negotiation Program
Jun 06, 2023
|
Emel Akan
Jun 06
|
Frontline Health
|
Dan Skorbach
HPV Vaccine: Is It Even Worth It?
Apr 25, 2023
|
Dan Skorbach
Apr 25
|
Companies
|
Naveen Athrappully
Merck’s COVID-19 Drug Fails to Show ‘Statistically Significant Reduction’ in Infection Risk
Feb 22, 2023
|
Naveen Athrappully
Feb 22
|
CCP Virus
|
Jack Phillips
Researchers Link COVID-19 Drug to New Virus Mutations in Patients
Feb 02, 2023
|
Jack Phillips
Feb 02
|
Companies
|
Reuters
Merck Opts to Develop, Sell Cancer Vaccine With Moderna
Oct 13, 2022
|
Reuters
Oct 13
|
WORLD
|
Cindy Liu
Merck’s Antiviral COVID-19 Pill Approved in Singapore
May 02, 2022
|
Cindy Liu
May 02
|
Businesses in COVID-19
|
Reuters
Merck Raises 2022 Forecast as COVID Pill, Cancer Drug Fuels Profit Beat
Apr 29, 2022
|
Reuters
Apr 29
|
Chinese Regime
|
Frank Fang
FDA Rejects Eli Lilly’s China-Developed Cancer Drug
Mar 25, 2022
|
Frank Fang
Mar 25
|
Businesses in COVID-19
|
Reuters
Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill
Feb 04, 2022
|
Reuters
Feb 04
|
WORLD
|
Lorenz Duchamps
EU Approves Pfizer’s COVID-19 Pill for Adults at Risk of Severe Disease
Jan 28, 2022
|
Lorenz Duchamps
Jan 28
|
Vaccines & Safety
|
Katabella Roberts
Researchers Concerned CCP Virus Will Develop Resistance to New Pfizer, Merck Pills
Jan 24, 2022
|
Katabella Roberts
Jan 24
|
Companies
|
Reuters
Merck Expects COVID-19 Pill Molnupiravir to Be Effective Against Omicron
Jan 12, 2022
|
Reuters
Jan 12
|
Companies
|
Reuters
Italy to Receive 40,000 Merck Antiviral Drug Doses Next Week: Official
Jan 10, 2022
|
Reuters
Jan 10
|
Facts Matter
|
Roman Balmakov
Facts Matter (Jan. 7): Rejects FDA Request, Gives Agency 8 Months to Produce Pfizer’s Safety Data
Jan 07, 2022
|
Roman Balmakov
Jan 07
|
Vaccines & Safety
|
Katabella Roberts
India Won’t Add Merck’s COVID-19 Pill to National Treatment Protocol, Citing Safety Concerns
Jan 06, 2022
|
Katabella Roberts
Jan 06
|
Businesses in COVID-19
|
Naveen Athrappully
Merck Authorizes Indian Pharma Company to Manufacture and Supply Affordable COVID-19 Pills
Jan 05, 2022
|
Naveen Athrappully
Jan 05
|
